Tag: ALK inhibitor for NSCLC

Home / ALK inhibitor for NSCLC

Categories

Alectinib has been approved by the USFDA as adjuvant treatment for ALK-positive non-small cell lung cancer

Alectinib approved in the treatment of non-small cell lung cancer The Food and Drug Administration (FDA) has approved the drug Alecensa, made by Genentech, Inc. It can be used as an extra treatment f...
alk-inhibitor-for-nsclc

Scan the code